Clinical value of serum miR-1-3p as a potential circulating biomarker for abdominal aortic aneurysm

References

• Gao J, Cao H, Hu G, et al. The mechanism and therapy of aortic aneurysms. Signal Transduct Target Ther. 2023;8(1):1.
   PubMed Web of Science ®Google Scholar
• Moll FL, Powell JT, Fraedrich G, et al. Management of abdominal aortic aneurysms clinical practice guidelines of the European society for vascular surgery. Eur J Vasc Endovasc Surg. 2011;41(Suppl 1):S1–9. doi:10.1016/j.ejvs.2010.09.011.
   PubMed Web of Science ®Google Scholar
• Nordon IM, Hinchliffe RJ, Loftus IM, et al. Pathophysiology and epidemiology of abdominal aortic aneurysms. Nat Rev Cardiol. 2011;8(2):92–102. doi:10.1038/nrcardio.2010.180.
   PubMed Web of Science ®Google Scholar
• Smidfelt K, Nordanstig J, Davidsson A, et al. Misdiagnosis of ruptured abdominal aortic aneurysms is common and is associated with increased mortality. J Vasc Surg. 2021;73(2):476–483 e473. doi:10.1016/j.jvs.2020.06.047.
   PubMed Web of Science ®Google Scholar
• Memon AA, Zarrouk M, Agren-Witteschus S, et al. Identification of novel diagnostic and prognostic biomarkers for abdominal aortic aneurysm. Eur J Prev Cardiol. 2020;27(2):132–142. doi:10.1177/2047487319873062.
   PubMed Web of Science ®Google Scholar
• Agarwal V, Bell GW, Nam JW, et al. Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015;4:e05005. doi:10.7554/eLife.05005.
   Web of Science ®Google Scholar
• Rouleau S, Glouzon JS, Brumwell A, et al. 3’ UTR G-quadruplexes regulate miRNA binding. RNA. 2017;23(8):1172–1179. doi:10.1261/rna.060962.117.
   PubMed Web of Science ®Google Scholar
• Mitchell PS, Parkin RK, Kroh EM, et al. Circulating ­microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008;105(30):10513–10518. doi:10.1073/pnas.0804549105.
   PubMed Web of Science ®Google Scholar
• Su X, Nie M, Zhang G, et al. MicroRNA in cardio-metabolic disorders. Clin Chim Acta. 2021;518:134–141. doi:10.1016/j.cca.2021.03.024.
   PubMed Web of Science ®Google Scholar
• Kumar S, Boon RA, Maegdefessel L, et al. Role of noncoding RNAs in the pathogenesis of abdominal aortic aneurysm. Circ Res. 2019;124(4):619–630. doi:10.1161/CIRCRESAHA.118.312438.
   PubMed Web of Science ®Google Scholar
• Zhou SS, Jin JP, Wang JQ, et al. miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges. Acta Pharmacol Sin. 2018;39(7):1073–1084. doi:10.1038/aps.2018.30.
   PubMed Web of Science ®Google Scholar
• Tang Y, Fan W, Zou B, et al. TGF-beta signaling and microRNA cross-talk regulates abdominal aortic aneurysm progression. Clin Chim Acta. 2021;515:90–95. doi:10.1016/j.cca.2020.12.031.
   PubMed Web of Science ®Google Scholar
• Li M, Chen X, Chen L, et al. MiR-1-3p that correlates with left ventricular function of HCM can serve as a potential target and differentiate HCM from DCM. J Transl Med. 2018;16(1):161. doi:10.1186/s12967-018-1534-3.
   PubMedGoogle Scholar
• Badacz R, Kleczyński P, Legutko J, et al. Expression of miR-1-3p, miR-16-5p and miR-122-5p as possible risk factors of secondary cardiovascular events. Biomedicines. 2021;9(8):1055. doi:10.3390/biomedicines9081055.
   PubMed Web of Science ®Google Scholar
• Gao M, Yu T, Liu D, et al. Sepsis plasma-derived exosomal miR-1-3p induces endothelial cell dysfunction by targeting SERP1. Clin Sci (Lond). 2021;135(2):347–365. doi:10.1042/CS20200573.
   PubMed Web of Science ®Google Scholar
• Li T, Jing J, Sun L, et al. The SNP rs4591246 in pri-miR-1-3p is associated with abdominal aortic aneurysm risk by regulating cell phenotypic transformation via the miR-1-3p/TLR4 axis. Int Immunopharmacol. 2023;118:110016. doi:10.1016/j.intimp.2023.110016.
   PubMed Web of Science ®Google Scholar
• Owens DK, Davidson KW, Krist AH, et al. Screening for abdominal aortic aneurysm: US preventive services task force recommendation statement. JAMA. 2019;322(22):2211–2218. doi:10.1001/jama.2019.18928.
   PubMed Web of Science ®Google Scholar
• Huang HY, Lin YC, Cui S, et al. miRTarBase update 2022: an informative resource for experimentally validated miRNA-target interactions. Nucleic Acids Res. 2022;50(D1):D222–D230. doi:10.1093/nar/gkab1079.
   PubMed Web of Science ®Google Scholar
• McGeary SE, Lin KS, Shi CY, et al. The biochemical basis of microRNA targeting efficacy. Science. 2019;366(6472):eaav1741. doi:10.1126/science.aav1741.
   PubMed Web of Science ®Google Scholar
• Boileau A, Lino Cardenas CL, Courtois A, et al. MiR-574-5p: a circulating marker of thoracic aortic aneurysm. Int J Mol Sci. 2019;20(16):3924.
   PubMed Web of Science ®Google Scholar
• Thanigaimani S, Iyer V, Bingley J, et al. Association between serum MicroRNAs and abdominal aortic aneurysm diagnosis and growth. Eur J Vasc Endovasc Surg. 2023;65(4):573–581. doi:10.1016/j.ejvs.2022.12.028.
   PubMed Web of Science ®Google Scholar
• Ginckels P, Holvoet P. Oxidative stress and inflammation in cardiovascular diseases and cancer: role of non-coding RNAs. Yale J Biol Med. 2022;95(1):129–152.
   PubMed Web of Science ®Google Scholar
• Sun TY, Li YQ, Zhao FQ, et al. MiR-1-3p and MiR-124-3p synergistically damage the intestinal barrier in the ageing Colon. J Crohns Colitis. 2022;16(4):656–667. doi:10.1093/ecco-jcc/jjab179.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Yin H, Zheng XL. MicroRNA-1 inhibits myocardin-induced contractility of human vascular smooth muscle cells. J Cell Physiol. 2010;225(2):506–511. doi:10.1002/jcp.22230.
   PubMed Web of Science ®Google Scholar
• Sysol JR, Chen J, Singla S, et al. Micro-RNA-1 is decreased by hypoxia and contributes to the development of pulmonary vascular remodeling via regulation of sphingosine kinase 1. Am J Physiol Lung Cell Mol Physiol. 2018;314(3):L461–L472. doi:10.1152/ajplung.00057.2017.
   PubMed Web of Science ®Google Scholar
• Fan Z, Liu S, Zhou H. LncRNA H19 regulates proliferation, apoptosis and ECM degradation of aortic smooth muscle cells via miR-1-3p/ADAM10 axis in thoracic aortic aneurysm. Biochem Genet. 2022;60(2):790–806. doi:10.1007/s10528-021-10118-y.
   PubMed Web of Science ®Google Scholar
• De Haro J, Bleda S, Acin F. C-reactive protein predicts aortic aneurysmal disease progression after endovascular repair. Int J Cardiol. 2016;202:701–706. doi:10.1016/j.ijcard.2015.09.122.
   PubMed Web of Science ®Google Scholar
• Folsom AR, Yao L, Alonso A, et al. Circulating biomarkers and abdominal aortic aneurysm incidence: the atherosclerosis risk in communities (ARIC) study. Circulation. 2015;132(7):578–585. doi:10.1161/CIRCULATIONAHA.115.016537.
   PubMed Web of Science ®Google Scholar
• Wanhainen A, Mani K, Golledge J. Surrogate markers of abdominal aortic aneurysm progression. Arterioscler Thromb Vasc Biol. 2016;36(2):236–244. doi:10.1161/ATVBAHA.115.306538.
   PubMed Web of Science ®Google Scholar
• Yavarimanesh M, Cheng HM, Chen CH, et al. Abdominal aortic aneurysm monitoring via arterial waveform analysis: towards a convenient point-of-care device. NPJ Digit Med. 2022;5(1):168. doi:10.1038/s41746-022-00717-3.
   PubMed Web of Science ®Google Scholar
• Kablak-Ziembicka A, Badacz R, Przewlocki T. Clinical application of serum microRNAs in atherosclerotic coronary artery disease. J Clin Med. 2022;11(22):6849.
   Web of Science ®Google Scholar
• Parizadeh SM, Ferns GA, Ghandehari M, et al. The diagnostic and prognostic value of circulating microRNAs in coronary artery disease: a novel approach to disease diagnosis of stable CAD and acute coronary syndrome. J Cell Physiol. 2018;233(9):6418–6424. doi:10.1002/jcp.26324.
   PubMed Web of Science ®Google Scholar
• Peyronnel C, Totoson P, Martin H, et al. Relevance of circulating markers of endothelial activation for cardiovascular risk assessment in rheumatoid arthritis: a narrative review. Life Sci. 2023;314:121264. doi:10.1016/j.lfs.2022.121264.
   PubMed Web of Science ®Google Scholar
• Mao N, Gu T, Shi E, et al. Phenotypic switching of vascular smooth muscle cells in animal model of rat thoracic aortic aneurysm. Interact Cardiovasc Thorac Surg. 2015;21(1):62–70. doi:10.1093/icvts/ivv074.
   PubMed Web of Science ®Google Scholar
• Quintana RA, Taylor WR. Cellular mechanisms of aortic aneurysm formation. Circ Res. 2019;124(4):607–618. doi:10.1161/CIRCRESAHA.118.313187.
   PubMed Web of Science ®Google Scholar
• Trollope AF, Golledge J. Angiopoietins, abdominal aortic aneurysm and atherosclerosis. Atherosclerosis. 2011;214(2):237–243. doi:10.1016/j.atherosclerosis.2010.08.051.
   PubMed Web of Science ®Google Scholar
• Zhang M, Sui W, Cheng C, et al. Erythropoietin promotes abdominal aortic aneurysms in mice through angiogenesis and inflammatory infiltration. Sci Transl Med. 2021;13(603):eaaz4959. doi:10.1126/scitranslmed.aaz4959.
   Web of Science ®Google Scholar
• Tedesco MM, Terashima M, Blankenberg FG, et al. Analysis of in situ and ex vivo vascular endothelial growth factor receptor expression during experimental aortic aneurysm progression. Arterioscler Thromb Vasc Biol. 2009;29(10):1452–1457. doi:10.1161/ATVBAHA.109.187757.
   PubMed Web of Science ®Google Scholar